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Abstract
Background: Multi-detector computed tomography angiography (MDCTA) has been increasingly used in the
evaluation of the coronary arteries. The purpose of this study was to review the literature on the diagnostic
performance of MDCTA in the acute setting, for the detection of non-ST-elevation myocardial infarction
(NSTEMI) and unstable angina pectoris (UAP).
Methods: A Pubmed and manual search of the literature published between January 2000 and June 2007 was
performed. Studies were included that compared MDCTA with clinical outcome and/or CA in patients with acute
chest pain, presenting at the emergency department. More specifically, studies that only included patients with
initially negative cardiac enzymes suspected of having NSTEMI or UAP were included. Summary estimates of
diagnostic odds ratio (DOR), sensitivity and specificity, negative (NLR) and positive likelihood ratio (PLR) were
calculated on a patient basis. Random-effects models and summary receiver operating curve (SROC) analysis were
used to assess the diagnostic performance of MDCTA with 4 detectors or more. The proportion of non
assessable scans (NAP) on MDCTA was also evaluated. In addition, the influence of study characteristics of each
study on diagnostic performance and NAP was investigated with multivariable logistic regression.
Results: Nine studies totalling 566 patients, were included in the meta-analysis: one randomised trial and eight
prospective cohort studies. Five studies on 64-detector MDCTA and 4 studies on MDCTA with less than 64
detectors were included (32 detectors n = 1, 16 detectors n = 2, 16 and 4 detectors n = 1). Pooled DOR was
131.81 (95%CI, 50.90–341.31). The pooled sensitivity and specificity were 0.95 (95%CI, 0.90–0.98) and 0.90
(95%CI, 0.87–0.93). The pooled NLR and PLR were 0.12 (95%CI, 0.06–0.21) and 8,60 (95%CI, 5.03–14,69).
The results of the logistic regressions showed that none of the investigated variables had influence on the
diagnostic performance or NAP
Conclusion: MDCTA of the coronary arteries performs good to excellent in the diagnosis of coronary artery
disease in the acute setting and it can be used for early exclusion of NSTEMI or UAP in patients in the emergency
department.
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Background
Acute chest pain accounts for approximately 6.5% of all
emergency department visits in the US [1,2]. Failure to
diagnose myocardial ischemia as a cause of acute chest
pain has serious implications and the triage of patients
with possible ischemia is often difficult. To reduce diag-
nostic error, many patients that present at the emergency
department are admitted for observation, even when no
initial ECG changes or elevated cardiac enzymes are
present. Emergency departments have therefore devel-
oped chest pain units and diagnostic protocols commonly
including serial cardiac enzyme evaluations and ECG's,
supplemented with some form of stress testing with or
without imaging [3]. Many of these patients are found to
have no acute coronary syndrome (ACS) and more than 2
million patients with acute chest pain are admitted to the
hospital without developing an ACS [4,5]. Data from Ger-
many reveal that the number of potentially unnecessary
hospital days is high, amounting to as much as 839 per
100 patients admitted for acute chest pain [6].
Non invasive access to coronary anatomy has become
available with the emergence of multi-detector computed
tomography (MDCTA) of the coronary arteries. Diagnos-
tic performance of MDCTA has been evaluated in many
studies [7]. Even though appropriate indications for
MDCTA remain largely work in progress, the technique
has been used as a tool to rule out ACS in the emergency
department. [8-16]
The purpose of our study was to review the literature and
perform a meta-analysis on the diagnostic performance of
multi-detector computed tomography angiography for
the exclusion of ACS in the emergency department. More
specifically, we focused on the early non-invasive diagno-
sis of non ST elevation myocardial infarction (NSTEMI)
with initially negative biomarkers and unstable angina
pectoris (UAP). A second aim was to investigate the influ-
ence of multiple independent study-related variables on
the diagnostic performance of MDCTA.
Methods
Study selection
A search in the Computer Retrieval of Information on Sci-
entific Projects (CRISP), Database of Abstracts of Reviews
of Effects (DARE), International Network of Agencies for
Health Technology Assessment (INAHTA) and Cochrane
Database of Systematic Reviews (CDSR) databases was
done from January 1998 to June 2007. The purpose was
to reveal the existence of structured reviews on MDCTA
for ruling out ACS in the emergency department. A struc-
tured review or systematic review is based on a thorough
review of the literature concerning a single topic but dif-
fers from a narrative review by statistically combining the
results of several studies into a single outcome measure,
by using techniques of meta-analysis. To search for origi-
nal articles, a structured search of the PUBMED database
from January 1998 to April 2007 was performed using an
elaborated form of a previously described search strategy
[17], by two authors (PV, OB). A second search was done
by the same authors with another method recently
described [18]. Both strategies can be found in Additional
file 1. Reference lists of review articles and cited articles
were used to locate additional studies. The following jour-
nals were hand-searched from January 1998 to March
2007: European Radiology, Radiology, Radiographics,
American Journal of Roentgenology, Journal of Computer
Assisted Tomography, Journal de Radiologie, Heart, The
Lancet, New England Journal of medicine, JAMA, Journal
of the American College of Cardiology, American Journal
of Cardiology, American Heart Journal, Circulation,
Hypertension, Circulation Research, European Heart Jour-
nal, British Medical Journal, Journal of Nuclear Cardiol-
ogy, Emergency Medicine English Dutch, French,
German, Italian and Spanish articles were also potentially
included because the authors were familiar with these lan-
guages. Finally the results of all the searches were fused
with bibliography software and duplicate publications
were automatically removed (Reference Manager Profes-
sional edition version 10, ISI research software).
Studies were included in the meta-analysis if they met the
following inclusion criteria: the data were acquired with a
multi-detector CT-scanner with at least four detectors;
catheter angiography was used as the reference standard
and/or clinical follow up was obtained in all patients con-
cerning the presence of UAP or NSTEMI ; the criteria for a
positive result of MDCTA and CA were explicitly defined
as 50 percent or greater diameter stenosis; the criteria for
a positive clinical outcome (diagnosis of NSTEMI or UAP)
where coherent with actual clinical standards and were
explicitly defined; the absolute numbers of true-positive,
false-negative, false-positive, and true-negative test results
were available or could be derived from the available data
or from the authors. These absolute numbers were
accepted if they were derived on a per segment basis, or on
a per patient basis. For segmental analysis an adapted
American Heart Association 15 segment scheme of the
coronary tree was used [19].
Exclusion criteria were: not an acute ACS setting or
MDCTA later than 24 hours after the onset of the acute
event; unknown status of cardiac biomarkers or positive
markers; review article; not all patients were tested with
the reference test (Table 1).
The results of this search were analysed by two independ-
ent radiologists (PV, OB) as follows: Each investigator
independently evaluated the retrieved studies for possible
inclusion. In the case of conflicting findings as to whetherBMC Cardiovascular Disorders 2007, 7:39 http://www.biomedcentral.com/1471-2261/7/39
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a paper should be included, a decision was reached by
consensus. In a first round articles were eliminated that
clearly did not match the inclusion criteria, on the basis of
the title or the abstract. In a second round, hard copies of
the papers that gave rise to doubt on the basis of their
abstracts were obtained and the full text was read, again
eliminating a group of papers. The final group consisted
of the included papers.
Inclusion of studies was guided by the quality of the study
design and report. A formal system for quality evaluation,
Quality Assessment of Diagnostic Accuracy Studies (QUA-
DAS,20), with a maximum of 14 points was used for judg-
ing quality in the final evaluation of included papers (Fig.
1, round 3). A score of >/= 12 was considered acceptable.
Data extraction
The study parameters where extracted first independently
and subsequently by consensus if a disagreement existed
between the observers concerning the numeric value of a
parameter (PV, ID). Data were extracted from the original
articles taking into account the Standards for Reporting of
Diagnostic Accuracy (STARD) checklist [21].
The absolute numbers of FN, FP, TP, TN were retrieved,
calculated or requested from the authors. The numbers
were calculated with Bayes theorem if only values for sen-
sitivity, specificity, and predictive values were reported.
This was done separately for per patient and per segment
data, if available.
MDCTA was considered true-positive per patient, or per
segment if at least one significant stenosis (>= 50% diam-
eter stenosis) was found on MDCTA in, respectively, the
investigated patient, or segment and confirmed on CA.
MDCTA was considered true-negative if significant sten-
oses were correctly ruled out. MDCTA was considered
false-negative if no significant stenoses were found on
MDCTA and CA revealed at least one significant stenosis.
MDCTA was considered false-positive if it revealed at least
one stenotic stenosis and CA showed no significant sten-
oses. If no CA was done, positive clinical outcome of UAP
or NSTEMI was the positive reference identifier, and
absence of UAP or NSTEMI was the negative reference
identifier with an analogue classification scheme as
above.
Additional study characteristics were extracted (Table 2).
Data synthesis and statistical analysis
Results are expressed as mean with 95% confidence inter-
vals (95%CI), unless otherwise specified.
Interobserver agreement for study selection was evaluated
with Cohen's Kappa test in which a value higher than 0.8
is considered to imply very good to excellent agreement.
The three rounds of selection were evaluated.
Flow diagram of the reviewing process Figure 1
Flow diagram of the reviewing process.
Table 1: Number and reasons for exclusion of articles that were 
reviewed in full-text.
Not an acute ACS setting 71
Unknown status of/or positive biomarkers 6
Review article 6
No comparison with reference standard in all cases 1
Total 84BMC Cardiovascular Disorders 2007, 7:39 http://www.biomedcentral.com/1471-2261/7/39
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The main analysis was performed at the patient level, as
most studies focused on this level of information. We
evaluated potential heterogeneity and inconsistency
between publications [22,23] expressed with the Higgins
and Thompson index which calculates the I2 statistic, and
is a derivative of Cochran's Q [24-26]. Cochran's Q dis-
plays a low power for detection of inconsistency when the
number of studies is low, and a too high power when the
number of studies is high.
Publication bias was assessed according to the method
introduced by Sterne and Egger [27,28]. The existence of
publication bias is expressed as an intercept value, and is
0 if no publication bias is found. A Funnel plot for graphic
analysis of publication bias was constructed. A funnel plot
is a plot of some measure of each study's sample size, such
as the standard error, as function of its effect size. A distri-
bution of the datapoints as an inverted funnel indicates
that publication bias is highly unlikely. Calculations were
performed with Statsdirect (StatsDirect Ltd. StatsDirect
statistical software, England).
Summary estimates for sensitivity, specificity, positive
likelihood ratio (PLR), negative likelihood ratio (NLR)
and the overall diagnostic performance expressed in the
diagnostic odds ratio (DOR) were calculated. This was
done with a random effects model, which takes into
account the variability between studies [29].
Subsequently, we performed a random effects SROC anal-
ysis to estimate the relationship between sensitivity and
specificity, taking into account potential differences in
positivity criterion (that is, the threshold used to mark a
test as positive) and other factors of heterogeneity
between settings. In a SROC analysis the logits (log odds)
of sensitivity and 1-specificity are summed to calculate D,
the log of the diagnostic odds ratio, and the logits are sub-
tracted to calculate S, a proxy for the positivity criterion of
the diagnostic test [30-32]. Then, a linear regression
model D = a + bS is estimated, weighted by the inverse of
the variance of D. Values for area under the curve (AUC)
and Q* were calculated with their respective standard
error (SE). Q* is the point of intersection of the SROC
curve where SE and SP are equal and is a statistic that
describes global diagnostic performance [33].
A multivariable logistic meta-regression was performed to
investigate the influence of multiple explanatory variables
on the diagnostic performance.
The evaluated variables included: Male/female ratio,
mean age of patients, number of included patients, out-
come used (CA or clinical), non-assessable patients
excluded before analysis of diagnostic performance coded
as a dichotomous variable (yes/no), number of detectors
in the scanner used and pre-test probability of the cohort
(low, intermediate, high, all or unknown) as indicated by
the authors. Other variables such as scan and technique
related variables were not investigated since in a prior
Table 2: Study Characteristics
Year Type Det Age M/F Prob INC NAP Outc NCA
White8 2005 PC 16 51 1.03 All** 69 0 CLIN -
Gallagher9 2006 PC 64 49 0.53 Low 96 0.07 CLIN 5
Hoffmann10 2006 PC 16/64 57 0.53 All** 40 0 CLIN -
Hoffmann11 2006 PC 64 54 0.58 All** 106 0.03 CLIN 8
Olivetti12 2006 PC 16 59 0.61 U 31 0 CA 31
Sato13 2006 PC 4/16 60 0.85 U 34 0.09 CLIN -
Goldstein14 2007 RCT 64 48 0.43 Low 99 0.11 CLIN 12
Meijboom15 2007 PC 64 59 0,76 Low 33 0 CA 33*
Rubinshtein16 2007 PC 64 56 1.76 Int 58 0 CLIN 17
Type: Study type.
RCT: Randomized controlled trial.
PC: Prospective cohort.
Det: Number of detectors.
M/F: Male/Female ratio.
Prob: Pre-test probability.
INC: Number of included patients.
NAP: Non assessable proportion of patients = Ratio of non-diagnostic versus included patients.
Outc: reference standard used.
NCA: Number of patients that underwent Conventional Angiography.
Clin: Clinical.
U: Unknown.
*:only a fraction of the patients were included: the patients that clearly had negative biomarkers and were categorized as "low risk" in this study.
**: included patients with pre-test probability ranging from low to highBMC Cardiovascular Disorders 2007, 7:39 http://www.biomedcentral.com/1471-2261/7/39
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meta-analysis these variables did not show any important
influence [34] or could not be obtained in detail (such as
coronary calcium score or pre-test probability). Variables
with a significance level of p <= 0.10 were added to the
multivariable meta-regression model in a stepwise for-
ward manner. A variable was kept in the model if p < 0.05.
A p <= 0.10 was used to add variables to the multivariable
model whereas a p <= 0.05 was used to retain variables in
the model. For adding variables to the model a higher p-
value was chosen so as to increase the power of finding
important effects. The beta-coefficients and correspond-
ing relative diagnostic odds ratios from the meta-regres-
sion analysis indicated the effect of each variable on the
overall diagnostic performance.
The proportion of non-assessable patients (NAP) was
pooled with a random effects model and evaluated as
dependent variable in a multivariable regression analysis
to evaluate which variables influenced this proportion.
NAP was defined as the ratio of technical failure or non-
diagnostic scans to the final number of included patients
(Fig 2). The same variables except for the exclusion of
non-assessable segments were tested as above. Software
used for the calculation of pooled estimates, SROC analy-
ses and all regressions was Meta-DiSc (version 1.3 Clinical
Biostatistics Unit-Hospital Ramon y Cajal, Madrid, Spain)
and/or Statsdirect
Results
Study selection and data extraction
The search in the CRISP, DARE, INAHTA and CDSR data-
bases revealed no structured reviews or meta-analyses on
the diagnostic performance of MDCTA for the assessment
of NSTEMI or UAP in the acute setting.
The Pub-med search and the manual search for original
articles resulted in 650 articles. 557 articles were excluded
on the basis of their title or abstract, with 93 remaining for
further evaluation. From these 93 articles, 9 where finally
included in the meta-analysis [8-16]. Reasons of exclusion
and numbers of 84 of these 93 studies are tabulated in
Table 1. Five studies on 64-detector MDCTA and 4 studies
on MDCTA with less than 64 detectors were included (32
detectors n = 1, 16 detectors n = 2, 16 and 4 detectors n =
1). One study was partially included (Table 2) since only
a clearly defined fraction of the study patients were
patients with negative biomarkers [15]. A flow diagram of
the review process is given in Figure 1. In Additional file 2
the studies that were excluded were cited and classified
according to Table 1.
Inter-observer agreement for the selection of articles
between the two readers was 0.84, 0.87 and 1.0 for the
first to third round respectively.(Cohen's Kappa).
Important study characteristics are displayed in Table 2.
All selected studies had a Quadas score of 14.
Data synthesis and statistical analysis
A total of 566 patients where analysed. Only one study
supplied information at the segment level, so that pooled
analysis was only undertaken at the patient level.
Heterogeneity was not present among the studies when
calculating the pooled DOR and NLR (I2, 0%), but was
considerable for SE, SP and PLR (I2, 43.0%; 68.7%; 62.2%
respectively), which justifies our choice of a random
effects model.
Publication bias was not present. (Intercept 0.89; p =
0.49); A funnel plot of the studies included is given in Fig-
Flowdiagram of patient inclusion with patient categories used  in summarizing data Figure 2
Flowdiagram of patient inclusion with patient categories used 
in summarizing data. In the studies analysed, from the eligible 
patients only a part was enrolled in the studies. The patients 
that were finally included was the subset of enrolled patients 
that completed the full protocol and that had diagnostic 
scans. Non assessable proportion (NAP) was the ratio of 
non-diagnostic patients or technical failures to the finally 
included patient.BMC Cardiovascular Disorders 2007, 7:39 http://www.biomedcentral.com/1471-2261/7/39
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ure 3. It shows a good conformation to the ideal, funnel
shaped distribution.
Raw data and pooled sensitivity, and specificity are sum-
marized in Table 3.
The pooled sensitivity, specificity, NLR, PLR and the DOR
are graphically displayed as forest plots in Fig. 4, 5, 6, 7, 8
and show the following values: Pooled DOR was 134.39
(95%CI, 53.81–335.64). The pooled sensitivity and spe-
cificity were 0.95 (95%CI, 0.90–0.98) and 0.90 (95%CI,
0.87–0.93). The pooled NLR and PLR were 0.12 (95%CI,
0.06–0.21) and 8.60 (95%CI, 5.03–14.70).
SROC plot is found in Figure 9 and displays an excellent
value for AUC (0.97, SE 0.01) and Q* (0.92, SE 0.01).
Pooled NAP was 0.03 (95%CI, 0.01 to 0.07)
The results of the logistic (meta-)regressions showed that
none of the investigated variables had influence on the
diagnostic performance or NAP.
Discussion
Our analysis of the available literature on MDCTA for the
diagnosis of NSTEMI and/or UAP revealed that the overall
pooled estimates of sensitivity and specificity on a patient-
level were good to excellent. Furthermore, the pooled esti-
mates of NLR and PLR (0.12 and 8.60 repectively) and the
results of the logistic (meta-) regressions revealed that the
test can be used as a very reliable imaging modality to rule
out NSTEMI and UAP in an acute setting, irrespective of
scanner hardware and certain patient characteristics such
as age or gender. The number of non-diagnostic scans was
as low as 3%, which showed that the technique seems to
be robust. Moreover, detailed statistical analysis showed
that this meta-analysis did not suffer from frequently
occurring problems such as publication bias or extreme
heterogeneity/inconsistency between studies.
A previous meta-analysis [34] that studied MDCTA in
comparison with CA in a non-acute setting revealed
important heterogeneity and some publication bias, espe-
cially when the analysis was done on a per segment basis,
and demonstrated a prominent influence of the number
of detectors on the number of non-assessable segments
and diagnostic performance. Also the exclusion of seg-
ments before analysis had an important influence on
diagnostic performance. The reason that these effects are
statistically not demonstrable in the current study is prob-
ably due to the rather small sample and to the type of
analysis, that was done exclusively on a per patient level.
This is an important observation: MDCTA can probably
be used as a reliable technique to rule out NSTEMI or UAP
Graphical representation of publication bias Figure 3
Graphical representation of publication bias. The dots, each 
representing one study are conforming to a triangular form, 
meaning that publication bias is low.
Table 3: Raw data from all the studies.
Study TP/(TP+FN) FP/(TN+FP) Sensitivity (95% CI) Specificity (95% CI)
White8 10/12 55/57 0.83 0.52 - 0.98 0.96 0.88 - 1.00
Gallagher9 6/7 72/78 0.86 0.42 - 1.00 0.92 0.840 - 0.97
Hoffmann10 5/5 26/35 1.00 0.48 - 1.00 0.74 0.57 - 0.87
Hoffmann11 14/14 73/89 1.00 0.77 1.00 0.82 0.73 - 0.89
Olivetti12 15/18 13/13 0.83 0.59 - 0.96 1.000 0.75 - 1.00
Sato13 21/22 8/12 0.95 0.77 - 1.00 0.89 0.52 - 0.98
Goldstein14 8/8 88/91 1.000 0.63 - 1.00 0.97 0.91 - 0.94
Meijboom15 28/28 4/5 1.000 0.88 - 1.00 0.80 0.28 - 0.96
Rubinshtein16 20/20 35/38 1.000 0.83 - 1.00 0.92 0.79 - 0.98
TP: True positive.
TN: True negative.
FP: False positive.
FN: False negative.
95%CI: 95% Confidence intervals.BMC Cardiovascular Disorders 2007, 7:39 http://www.biomedcentral.com/1471-2261/7/39
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in a acute setting and the test can be done very quickly and
does not require complex patient preparation or logistic
resources. The scan can be performed in the first hours
after the onset of the clinical complaints and when nega-
tive, the patient can be discharged from the emergency
department immediately. In the studies that were pooled
in this meta-analysis, there was one randomized study
that prooved that the average time from randomization to
diagnosis was significantly shorter in the MDCTA arm
than in the other arm (3.4 h versus 15 h)[14].
Although the purpose of this study was not to formally
study the reliability of MDCTA to exclude all causes of
chest pain, it is apparent from the individual data from
most studies in this series that alternative diagnoses
besides coronary disease can often be ruled out.
Other imaging techniques have been used to develop a
quick and efficient triage strategy for acute chest pain in
the emergency department. Nuclear medicine techniques
and to a much lesser degree, echocardiography, have been
extensively tested, and there is a large body of literature
supporting its use in these circumstances [35]. In 2003 a
joint task force of the American College of Cardiology, the
American Heart Association and the American Society for
Nuclear Cardiology published guidelines for the use of
Myocardial perfusion imaging (MPI) [36]. The task force
gave a class 1 recommendation to the use of acute rest MPI
for the assessment of patients presenting with a possible
Forest plot of specificity on a per patient basis Figure 5
Forest plot of specificity on a per patient basis.
Forest plot of sensitivity on a per patient basis Figure 4
Forest plot of sensitivity on a per patient basis.BMC Cardiovascular Disorders 2007, 7:39 http://www.biomedcentral.com/1471-2261/7/39
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acute coronary syndrome in whom initial markers and the
ECG are non diagnostic. A randomized study [37] showed
that MPI improves triage and that unnecessary hospitali-
sation was reduced among patients without acute ischae-
mia, without reducing appropriate admission for patients
with acute ischemia. Wether MDCTA can be recom-
mended as a substitute for MPI needs to be investigated
further, since the total number of patients in this study is
low.
Radiation dose may be a matter of debate. A clear disad-
vantage of MDCTA is the relatively high radiation dose
that goes with the examination, with average doses rang-
ing from 10 to 20 mS [38]. How this relates to the dose of
MPI now and in the future is a matter that goes beyond
this discussion, but it may be anticipated that radiation
dose reducing protocols for MDCTA will have an impor-
tant impact [38].
Recently a few studies have described the use of three
dimensional whole heart MRI for imaging the coronary
tree in unstable patients. This technique has two advan-
tages over MDCTA namely the lack of ionising radiation
and no need to inject iodine containing contrast agents
[39,40].
Some limitations of this study have to be acknowledged.
We put the presence of obstructive coronary disease and
positive biomarkers on a similar level as an outcome of
positive diagnosis. This is clearly an oversimplification
Forest plot of negative likelihood ratio on a per patient basis Figure 7
Forest plot of negative likelihood ratio on a per patient basis. LR: Likelihood ratio.
Forest plot of positive likelihood ratio on a per patient basis Figure 6
Forest plot of positive likelihood ratio on a per patient basis. LR: Likelihood ratio.BMC Cardiovascular Disorders 2007, 7:39 http://www.biomedcentral.com/1471-2261/7/39
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and would suggest that every patient with obstructive dis-
ease has an ACS. This is obviously not the case. In the
logistic meta-regression, there was however no influence
of the type of outcome used on the diagnostic perform-
ance.
SROC curve of per patient analysis Figure 9
SROC curve of per patient analysis. AUC: Area under the curve. SE: Standard error. Q*: Point of intersection of the SROC 
curve where SE and SP are equal.
Forest plot of diagnostic odds ratio on a per patient basis Figure 8
Forest plot of diagnostic odds ratio on a per patient basis. OR: Odds ratio.BMC Cardiovascular Disorders 2007, 7:39 http://www.biomedcentral.com/1471-2261/7/39
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The number of patients that was pooled in this analysis is
rather low and the conclusions may be misleading to
some degree. However, one of the studies incorporated
was a randomized trial, and the conclusions drawn from
this individual study were in line with the global conclu-
sion, which is supporting the suggestion that the pooled
conclusions are probably realistic [14]. Another, probably
more important limitation is that detailed information on
factors that technically limit MDCTA, such as high cal-
cium score, irregular rythm, the presence of stents and
dyspnea [41-44] was not mentioned in most studies, or at
least not amenable to pooling. The same was true for pre-
test probability of the patient populations. This may cast
some doubt on the potential to generalize the results to all
patient populations.
The question may be asked why we did a meta-analysis on
acute patients, since meta-analysis of MDCTA of the coro-
nary arteries has already been performed previously [34].
We considered the studies in the acute setting as a differ-
ent and interesting subgroup for two reasons. First, the
studies that were included looked at outcome in a broader
sense: clinical and/or conventional angiography. None of
the studies included here has been included in this previ-
ous meta-analysis. Second the acute setting was supposed
to include patients that may have a more dramatic clinical
presentation in which MDCTA might result in more non-
diagnostic scans. This selection resulted, as quoted
already, in a small pooled group, with all attendant draw-
backs.
Conclusion
The conclusion of this study is that MDCTA may be a safe
and quick diagnostic technique to rule out NSTEMI or
UAP in the emergency department. Future randomized
studies should focus on including subtypes of patients
that are known to be more difficult to image with MDCTA
or to determine what the precise indication is for MDCTA
and the place in the diagnostic algorithm. Cost-effective-
ness studies should be done to investigate the economic
impact of using this technique to evaluate chest pain in an
acute setting.
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